C12Y 108/04011
Peptide-methionine -s-oxide reductase
Official title: Peptide-methionine (S)-S-oxide reductase (1.8.4.11)
C12Y108/04011 (Peptide-methionine -s-oxide reductase) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 4
- Assignees
- 3
- Inventors
- 8
- Latest grant
- 23 Apr 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 2 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Reduction of oxidated methionine peptides for mass spectrometry23 Apr 2019US 10,266,866 B2California Institute of Technology
- Treatment of Methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA8 Jan 2019US 10,174,324 B2CuRNA, Inc.
- Treatment of methionine sulfoxide reductase a (MSRA) related diseases by inhibition of natural antisense transcript to MSRA17 Mar 2015US 8,980,858 B2CuRNA, Inc.
- Vectors expressing methionine sulfoxide reductase (msr)4 Sep 2025US 2025/0276094 A1University of South Florida
- Reduction of oxidated methionine peptides for mass spectrometry1 Jun 2017US 2017/0152541 A1California Institute of Technology
- Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra4 Jun 2015US 2015/0152425 A1CuRNA, Inc.
- Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra21 Mar 2013US 2013/0072546 A1CuRNA, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.